JIM
PDLI

Jupiter Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Jupiter Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,360,735
Closed -$2.88M – 513
2016
Q4 		$2.88M Buy
1,360,735
+298,892
+28% +$834K 0.05% 172
2016
Q3 		$3.56M Buy
1,061,843
+429,348
+68% +$1.36M 0.06% 186
2016
Q2 		$1.99M Buy
632,495
+254,160
+67% +$848K 0.04% 254
2016
Q1 		$1.26M Buy
+378,335
New +$1.18M 0.03% 285

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jupiter Investment Management's PDLI Position: Q1 2017 in Review

Jupiter Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 1,360,735 shares — an estimated $2.88M sold.

Jupiter Investment Management first reported a position in PDLI in Q1 2016 and held it in 4 quarters. The position peaked at $3.56M in Q3 2016. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

  • Jupiter Investment Management reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
  • Jupiter Investment Management sold 1,360,735 PDL BioPharma, Inc. shares in Q1 2017, an estimated $2.88M.
  • Jupiter Investment Management first reported a position in PDL BioPharma, Inc. in Q1 2016 and held it in 4 quarters.
  • Jupiter Investment Management's PDL BioPharma, Inc. position peaked at $3.56M in Q3 2016.
  • 174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on Jupiter Investment Management's 13F filing for Q1 2017, filed 27 Apr 2017.